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Potential Sites of PI-3 Kinase Function in the Endocytic 
Pathway Revealed by The PI-3 Kinase Inhibitor, Wortmannin 
Howard Shpetner, Marguerite Joly, David Hartley, and Silvia Corvera 
Program in Molecular Medicine and Department ofCell Biology, University of Massachusetts Medical School, Worcester, 
Massachusetts 01655 
Abstract. Previously we have shown that PDGF recep- 
tor mutants that do not bind PI-3 kinase internalize af- 
ter ligand binding, but fail to downregulate and de- 
grade. To define further the role of PI-3 kinase in 
trafficking processes in mammalian cells, we have in- 
vestigated the effects of a potent inhibitor of PI-3 ki- 
nase activity, wortmannin. At nanomolar concentra- 
tions, wortmannin i hibited both the transfer of PDGF 
receptors from peripheral compartments to juxtanu- 
clear vesicles, and their subsequent degradation. In
contrast, he delivery of soluble phase markers to lyso- 
somes, assessed by the accumulation of Lucifer yellow 
(LY) in perinuclear vesicles after 120 min of incuba- 
tion, was not blocked by wortmannin. Furthermore, 
wortmannin did not affect he rate of transferrin up- 
take, and caused only a small decrease in its rate of re- 
cycling. Thus, the effects of wortmannin on PDGFr 
trafficking are much more pronounced than its effects 
on other endocytic events. Unexpectedly, wortmannin 
also caused a striking effect on the morphology of en- 
dosomal compartments, marked by tubulation and en- 
largement of endosomes containing transferrin or LY. 
This effect was somewhat similar to that produced by 
brefeldin A, and was also blocked by pre-treatment of 
cells with aluminum fluoride (A1F4-). These results 
suggest two sites in the endocytic pathway where PI-3 
kinase activity may be required: (a) to sort PDGF re- 
ceptors from peripheral compartments to the lysosomal 
degradative pathway; and (b) to regulate the structure 
of endosomes containing lysosomally directed and re- 
cycling molecules. This latter function could be medi- 
ated through the activation of A1F4--sensitive GTP- 
binding proteins downstream of PI-3 kinase. 
p l-3 kinase was first discovered as an activity in im- munoprecipitates of receptor and nonreceptor ty- 
rosine kinases that phosphorylated the 3' position 
of the inositol ring in Pins, Plns(4)P, and Plns(4,5)P2 (37). 
The association of this lipid kinase activity with receptors 
that stimulate cellular growth suggested a role for PI-3 ki- 
nase in mitogenic signaling (3). More recently, the exist- 
ence of several biochemically distinct PI-3 kinases in mam- 
malian cells has been reported (32, 33), and PI-3 kinase 
activity has been implicated in numerous cellular pro- 
cesses including membrane ruffling, chemotaxis, traffick- 
ing of membrane proteins, and activation of kinases uch 
as protein kinase C (reviewed in reference 19). Thus, PI-3 
kinases in mammalian cells have emerged as a diverse 
family of proteins that are likely to be involved in multiple 
essential cellular processes. 
In yeast, deletions or mutations in the VPS34 gene, 
which encodes for the only detectable PI-3 kinase activity 
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in these ceUs (31), lead to a dramatic alteration i  the sort- 
ing of newly synthesized proteins to the yeast vacuole (13, 
14, 31), and to a deficiency in the degradation of internal- 
ized a factor receptors (23). Thus, in yeast, PI-3 kinase 
regulates protein sorting events in the secretory and prob- 
ably in the endocytic pathways. We have proposed that 
this sorting function of P1-3 kinase has been conserved in 
evolution, based on studies of mutant PDGF receptors im- 
paired in PI-3 kinase binding, which are altered in posten- 
docytic sorting to a degradative pathway (16, 17). The spe- 
cific mechanism whereby PI-3 kinase activity is required 
for PDGF receptor trafficking is not known. 
Recently it has been discovered that a potent fungal 
toxin, wortmannin, is a highly specific, potent inhibitor of 
the catalytic pl l0 subunit of mammalian PI-3 kinase (24, 
40). Wortmannin rapidly and irreversibly inhibits P1-3 ki- 
nase catalytic activity in intact cells with an 1D50 of 5-10 
nM. At these concentrations, wortmannin does not inhibit 
any other known protein or lipid kinase activities in cells. 
The specificity and potency of wortmannin has made it a 
widely utilized tool to dissect he cellular functions of PI-3 
kinase (5, 25). We have used wortmannin to explore fur- 
ther the role of PI-3 kinase on endocytic trafficking pro- 
cesses in mammalian cells. 
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Here we show a comparative analysis of the effects of 
wortmannin on the trafficking of three markers of the en- 
docytic pathway: transferrin, which internalizes and recy- 
cles through a well-characterized pathway involving sort- 
ing and recycling endosomes (15, 22), Lucifer yellow 
(LY), 1 a fluid phase marker which traffics to the lysosomal 
pathway, and the PDGF receptor (PDGFr), a transmem- 
brane protein which normally does not recycle, but is in- 
stead delivered to the lysosome for degradation. The re- 
suits presented here support the hypothesis that PI-3 
kinase plays a critical role in the sorting of the PDGFr ty- 
rosine kinase to the lysosomal pathway. Moreover, an un- 
expected role for PI-3 kinase in the control of membrane 
organelle structure is suggested by a dramatic effect of 
wortmannin on the morphology of endocytic organelles. 
Materials and Methods 
Cells 
Human HepG2 cells transfected with human 13-PDGF receptors (36), 
HeLa cells, and COS-7 cells were grown on glass coverslips or on 60 mm 
dishes to 80% confluence in DME supplemented with fetal calf serum 
(10%) (Upstate Biotechnology, Inc., Lake Placid, NY). In experiments in- 
volving fluid phase or transferrin uptake, cells were serum deprived for 2 
or 18 h with no detectable difference in the results obtained. For experi- 
ments in which PDGFr internalization was analyzed, cells were serum 
starved for 18 h, 
Immunofluorescence 
Cells were incubated at 37°C with PDGF-BB (20-50 ng/ml) (Upstate Bio- 
technology, Inc.) for the times indicated in each experiment. Cells were 
rapidly washed twice in ice-cold PBS, and fixed in 4% formaldehyde for 
15 min at room temperature. Cells were washed four times with PBS, and 
permeabilized by immersion in methanol at -20°C for 6 rain. Coverslips 
were briefly air dried, and stained with a monoclonal antibody raised 
against he receptor extracellular domain (PDGFR2; Oncogene Sciences, 
Mineola, NY), and goat antibodies to mouse IgG coupled to FITC or 
Rhodamine (Tago, Inc., Burlingame, CA). The fluid phase pathway was 
visualized by incubating cells with Lucifer yellow (5 mg/ml in DME) (Mo- 
lecular Probes, Eugene, OR) for the times indicated. Cells were then fixed 
and permeabilized asdescribed above, and the LY signal was enhanced by 
staining with an anti-LY polyclonal antibody (Molecular Probes) and goat 
antibodies to rabbit IgG coupled to FITC. The transferrin pathway was vi- 
sualized by incubation of cells with Texas red-labeled transferrin (1 p.g/ml 
in DME) (Molecular Probes), for the times indicated in each experiment, 
followed by fixation in 4 % formaldehyde for 15 rain at room temperature. 
Staining for 13COP and clathrin was done using rabbit antisera raised 
against 13COP (kindly provided by Dr. R. Klausner, NICHD, Bethesda, 
MD) or antisera raised against he COOH-terminal 15 amino acids of the 
clathrin heavy chain (18). Cells were mounted and visualized on a Zeiss 
IM-35 microscope, using a Nikon Apo 100/1.3 oil immersion lens. Data 
were recorded using a charge-coupled device (CCD) camera (Photomet- 
rics Ltd., Tucson, AZ) and visualized on a Silicon Graphics 4D/240 GTX. 
Where indicated, images were optically sectioned using digital imaging 
microscopy and a deconvolution algorithm that reverses the blurring in- 
troduced by the microscope optics (4). In these experiments, 20--30 serial 
two-dimensional images were recorded at 0.25-ram intervals using a thermo- 
electrically cooled CCD camera (Photometrics Ltd.). Each image was cor- 
rected for lamp intensity variations and photobleaching. Blurring of fluo- 
rescence from regions above and below the plane of focus was reversed 
using an iterative deconvolution algorithm based on the theory of ill- 
posed problems (4). 
Transferrin Uptake and Recycling 
125I-transferrin (31,000 cprn/l~g) was prepared using 10 i~g diferric trans- 
1. Abbreviations used in thispaper. BFA, brefeldin A; LY, Lucifer yellow; 
PDGFr, PDGF receptor; Tf, transferrin; TR, Texas red. 
ferrin (Boehringer-Mannheim Biochemicals, Indianapolis, IN) and Bol- 
ton Hunter reagent (Amersham, Arlington Heights, IL). To measure the 
rate of transferrin uptake, ceils were grown to 80% confluence in 24-well 
multiwell dishes. Endogenous transferrin was removed by two sequential 
40-min incubations in serum-free DME. Ceils were then incubated in 500 
p,1 of DME containing 0.2 ixg/ml 125I-transferrin for the times indicated. 
Ceils were washed four times in 1 ml of ice-cold PBS, and solubilized in 
0.1% SDS. Radioactivity in the lysates was measured by gamma counting. 
Nonspecific uptake was determined in incubations containing nonlabeled 
transferrin (10 ~g/ml). For the measurement of transferrin recycling, cells 
were incubated with 0.2 p,g/ml ~2~I-transferrin for 60 min, and washed four 
times in ice-cold PBS. Recycling was initiated by adding DME at 37°C 
containing nonlabeled transferrin (10 /~g/ml). At the times indicated 
monolayers were washed four times with 1 ml of ice-cold PBS, and solubi- 
lized in 0.1% SDS. Radioactivity in the lysates was measured by gamma 
counting. 
Measurement of Phosphoinositide Levels 
Cells were grown in 100 mm dishes to 70-80% confluency, and labeled by 
incubation for 3 h at 37°C in Krebs-Ringer/Hepes buffer containing 2 mM 
sodium pyruvate, 2% BSA and 0.5 mCi/ml of [32p]orthophosphate (N w 
England Nuclear, Boston, MA). Cell monolayers were washed three times 
with ice-cold PBS, and rapidly scraped into 750 ~1 of MeOH/1 M HC1 (1:1). 
Lipids were extracted with 400 Ixl of CHC13, deacylated, and analyzed by 
HPLC as described (1). 
Receptor Degradation 
Cells were grown to 80% confluence in 60 mm culture dishes, and incu- 
bated for 18 h in serum-free, methionine-free DME containing [35S]me- 
thionine (100 p.Ci/ml; Amersham) plus bovine serum albumin (1%), and 
then for 45 rain in DME containing bovine serum albumin (1%) and me- 
thionine (0.3 mg/ml; DME-BSA). Cells were then incubated without or 
with PDGF-BB (50 ng/ml) (Upstate Biotechnology, Inc.) for 2 h. Where 
indicated, wortmannin, brefeldin A (BFA), or a mixture of both toxins 
was added 10 rain before addition of PDGF. Cells were washed twice in 
ice-cold PBS, and lysed in 800 Ixl of a buffer containing 20 mM Tris (pH 
8.0), 150 mM sodium chloride, 1% Triton X-100, 1% sodium deoxycho- 
late, 0.1% SDS, 2 mM phenyl-methyl-sulfonyl fluoride, 1 mM benzami- 
dine, 1 mM 1,10 phenanthroline, 10 l~g/ml eupeptin, and 1 mM sodium 
vanadate (Sigma Chemical Co.). Receptors were immunoprecipitated 
with a polyclonal antibody to ct- and 13-PDGF receptors (Upstate Biotech- 
nology, Inc.), resolved on 7.5% polyacrylamide gels, transferred to nitro- 
cellulose, and exposed to autoradiographic film for 48 h. 
Effects of Wortmannin and BFA 
Wortmannin (Sigma Chemical Co.) was dissolved in DMSO to a final con- 
centration of 10 mM, dispensed into 5-1xl aliquots and stored at -80°C. 
Wortmannin aliquots were thawed and diluted 1:1,000 in ice-cold PBS to a 
final concentration of 10 p,M. Aliquots from this diluted stock were added 
directly to the cells to achieve the final concentrations indicated in each 
experiment. Because wortmannin is photosensitive and unstable in aque- 
ous solutions, it was routinely thawed, diluted, and added to cells within 
10 rain. Thawed aliquots were discarded. BFA (Sigma Chemical Co.) was 
dissolved in ethanol to a final concentration f50 raM. Aliquots from this 
stock were added directly to the cells to achieve the final concentration i - 
dicated in each experiment. 
Results 
Pathway of Internalization ofWild-type and Mutant 
PDGF Receptors 
Previously we have found that PDGFr containing muta- 
tions which specifically impair PI-3 kinase binding can in- 
ternalize, but fail to undergo down-regulation a d degra- 
dation in response to PDGF (17). To better define the 
steps after internalization where PI-3 kinase is required 
for PDGFr down-regulation, we initiated studies to define 
the trafficking pathway of PDGFr from the cell surface to 
lysosomes. The intracellular localization of both wild-type 
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Figure 1. Internalization fPDGF receptors and LY. Cells were 
simultaneously exposed to PDGF (20 ng/ml) and to LY (5 mg/ 
ml). After the indicated times of incubation at 37°C, cells were 
fixed, permeabilized, and stained for LY (bottom) and PDGF re- 
ceptors (top) using specific polyclonal and monoclonal antibod- 
ies, respectively. Secondary antibodies labeled with FITC or 
rhodamine were used to detect he polyclonal or monoclonal n- 
tisera, respectively. Arrowheads point to vesicular structures la- 
beled both with LY and PDGFr. Bars, 10 ~m. 
and mutant PDGFr was compared with that of LY, a lyso- 
somally directed fluid phase marker (Figs. 1 and 3), and 
that of transferrin (Tf), a marker for a well-characterized 
recycling pathway (see Figs. 2 and 4). 
HepG2 cells expressing wild-type receptors were ex- 
posed to PDGF and either LY (Fig. 1) or Tf (Fig. 2) at 
37°C for the times indicated. Cells were fixed and pro- 
cessed for immunofluorescence as described in Materials 
and Methods. As early as 10 rain after exposure of cells to 
PDGF, some colocalization of PDGFr and LY could be 
detected (Fig. 1, left). After 30 min, the PDGFr was found 
in larger, more perinuclear vesicles, and the co-localiza- 
tion with the fluid phase marker was very pronounced 
(Fig. 1, middle). After 120 min, much of the receptor signal 
disappeared ue to lysosomal degradation, whereas the 
pericentriolar LY staining remained very intense (Fig. 1, 
right). 
In contrast, at this level of resolution, a precise co-local- 
ization between the PDGFr and transferrin could not be 
detected at any time (Fig. 2). After 20-30 min of internal- 
ization, both PDGFr and transferrin were concentrated in 
a perinuclear region (Fig. 2, middle and right). However, 
transferrin was localized in more diffuse tubulo-vesicular 
structures which were clearly distinct from the larger vesi- 
cles containing PDGFr. These tubulo-vesicular elements 
probably correspond to the recycling endosome (15, 22). 
These results suggest that wild-type PDGFr molecules are 
sorted from recycling molecules relatively quickly (0-30 
min) after internalization, but continue to co-localize with 
lysosomally destined fluid-phase markers (Fig. 1). 
In marked contrast to the wild-type receptor, mutant re- 
ceptors which lack PI-3 kinase binding sites (F40/51) re- 
mained at the cell periphery even after 30-90 min of incu- 
Figure 2. Internalization of PDGF receptors and transferrin. 
Cells were simultaneously exposed to PDGF (20 ng/ml) and 
Texas red-labeled transferrin (5 p~g/ml). After the indicated 
times of incubation at 37°C, cells were washed, fixed, and stained 
with anti-PDGF receptor monoclonal ntibodies, and FITC-cou- 
pied anti-mouse secondary antibodies. Despite the appearance 
of both transferrin and PDGF receptors inthe same general vicin- 
ity (arrows), no precise co-localization was observed. Bars, 10 p,m. 
bation with PDGF (Fig. 3). These receptors were 
visualized in diffuse, peripheral structures, close to the 
plasma membrane (Fig. 3, top). In contrast to wild-type re- 
ceptors (Fig. 1) the F40/51 mutant displayed little co-local- 
ization with LY (Fig. 3, left). Interestingly, although the 
F40/51 mutant recycles to the cell surface after internaliza- 
tion (17), the mutant displayed little co-localization with 
the pericentriolar t ansferrin (Fig. 3, right), suggesting that 
the recycling of PDGFr mutants to the cell surface takes 
place through a pathway that does not involve the trans- 
ferrin recycling compartment. The peripheral localization 
of the receptor mutants, and their failure to co-localize 
with the bulk of the LY or Tf signals, suggest hat recep- 
tors impaired in PI-3 kinase binding are arrested in their 
trafficking at an early step after endocytosis. 
Effects of  Wortmannin on PDGF Receptor and 
L Y Trafficking 
To test further whether the differences between the traf- 
ficking pathways of wild-type and mutant PDGFr were 
due to differences in PI-3 kinase catalytic activity associ- 
ated with the receptor cytoplasmic domain, we analyzed 
the effects of wortmannin, a potent and specific inhibitor 
of PI-3 kinase. Cells were incubated without or with wort- 
mannin (50 riM) for 15 min, and then exposed to PDGF 
and LY. After 30 min of exposure of wortmannin-treated 
cells to PDGF, the receptor was found in a diffuse, periph- 
eral localization (Fig. 4, top right), which contrasted mark- 
edly with the vesicular, pericentriolar localization of re- 
ceptors in nontreated cells (Fig. 4, top left). Furthermore, 
the marked co-localization of PDGFr with LY (Fig. 4, top 
and bottom left) was lost in wortmannin-treated cells (Fig. 
4, top and bottom right). These results are similar to those 
obtained studying PDGFr mutants impaired in PI-3 kinase 
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Figure 3. Internalization ofF40/51 PDGF receptor mutants, LY, 
and transferrin. Cells expressing mutant (F40/51) receptors were 
incubated with PDGF and LY (left) or PDGF and transferrin 
(right) for 30 min at 37°C. Cells were fixed, and internalized mol- 
ecules visualized as described in Figs. 1 and 2. Arrows point to 
the peripheral structures containing most of the mutant PDGFr 
(top). The asterisk in the top right panel was placed in the peri- 
centriolar region containing the bulk of transferrin, to emphasize 
the lack of co-localization between PDGFr and the recycling en- 
dosome. Arrowheads point to internalized LY (bottom left) and 
transferrin (bottom right). Bars, 10 txm. 
binding (Fig. 3), and suggest hat PI-3 kinase catalytic ac- 
tivity is required for PDGFr  sorting from a specific periph- 
eral compartment to later steps in the lysosomal pathway. 
An unexpected finding in these studies was that, in addi- 
tion to causing a retention of PDGFr  in a peripheral com- 
partment, treatment of cells with wortmannin caused a 
pronounced change in the morphology of endosomes con- 
taining LY (Fig. 4, bottom right). This morphological 
change consisted in the appearance of a tubulated net- 
work, which in many cells almost completely replaced the 
vesicular structures containing LY. In addition to the ap- 
pearance of interconnected tubules, the amount of LY in 
wortmannin-treated cells appeared to be higher than that 
in untreated cells at early time points (Fig. 5, bottom). 
These alterations, however, did not appear to block the 
trafficking of LY to lysosomes, as a marked accumulation 
Figure 4. Effect of wortmannin on PDGF receptor and LY inter- 
nalization. Cells were incubated without (control) or with (WTM) 
wortmannin (50 nM) for 10 min, and then exposed to PDGF and 
LY for 30 min. Cells were fixed, and internalized molecules visu- 
alized as described in Figs. 1 and 2. Note the precise co-localiza- 
tion of PDGFr and LY in the left panels (arrowheads), which is 
not apparent in wortmannin-treated c lls in the right panels (ar- 
rowheads), and the appearance of interconnected tubules con- 
taining LY in response to wortmannin (bottom right). 
of the marker in large perinuclear vesicles was clearly visi- 
ble after 120 min of incubation (Fig. 5, extreme right). 
Effects of Wortmannin on the Transferrin 
Internalization Pathway 
To determine whether the morphological effect of wort- 
mannin was restricted to endosomes labeled by LY, we an- 
alyzed the effects of the toxin on the transferrin pathway. 
Analysis of endosomes containing Texas red (TR)-transfer- 
fin in HepG2 cells, monkey COS-7 cells, and human Hela 
cells also revealed a pronounced effect of wortmannin on 
endosome morphology (Fig. 6). In nontreated cells TR-  
transferrin was distributed throughout the cell in a distinct 
punctate pattern, with an area of concentration i the jux- 
tanuclear region which represents the recycling endosome 
(15, 22). In cells treated with wortmannin a striking in- 
crease in size, and decrease in number, of endosomes was 
observed (Fig. 6, broken arrow). Also apparent in many 
cells was the presence of fine tubules elongated from these 
enlarged endosomes (Fig. 6, arrows). The effect of wort- 
mannin was observed at concentrations as low as 10 nM, 
and was maximal at 50 nM (not illustrated). 
The effect of wortmannin occurred very rapidly, being 
detectable as early as 5 min after exposure of cells to the 
toxin (Fig. 7). After 20 min, a virtually complete transfor- 
mation of endosomes containing transferrin (Fig. 7) or LY 
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Figure 5. Effects of wortman- 
nin on the internalization of 
LY. Cells were incubated with- 
out (control) or with (WTM) 
wortmannin (50 riM) for 10 
rain, and exposed to LY for 
the times shown. Cells were 
fixed and LY visualized as de- 
scribed in Fig. 1. Arrowheads 
are aligned along extended tu- 
bules, and arrows point to jux- 
tanuclear vesicular structures 
apparent at later time points. 
(not shown) into an interconnected tubular network was 
apparent in many cells. To determine whether the mor- 
phological changes induced by wortmannin would result in 
functional alterations i  trafficking, we measured the rates 
of uptake and recycling of 125I-transferrin (Fig. 8). Treat- 
ment of cells with wortmannin had no detectable ffect on 
the rate of accumulation of 125I-transferrin (Fig. 8, left). 
However, the rate of recycling was altered by wortmannin 
(Fig. 8, right). Whereas the rate of transferrin recycling 
measured in the first 10 rain of the release assay appeared 
unaltered by wortmannin, the amount of transferrin re- 
leased subsequent to 10 min appeared to be decreased by 
30-40% in wortmannin-treated cells. After 40-50 min, 
however, all labeled transferrin was released from both 
untreated and wortmannin-treated cells. These results sug- 
gest that release of transferrin out of a specific compart- 
ment in the recycling pathway is slowed by wortmannin. 
Because the rates of transferrin and lipid recycling are 
similar (22), a decrease in transferrin recycling may reflect 
a general decrease in the rate of membrane flow out of 
early or recycling endosomes in response to wortmannin. 
This decrease could lead to the increased accumulation of 
LY and to the apparent enlargement of endosomes con- 
taining transferrin observed after treatment with the toxin 
(Figs. 5-7). 
The inhibition of PDGFr  trafficking and the changes in 
organelle morphology produced by wortmannin suggest 
that PI-3 kinase activity is required for at least wo pro- 
cesses in the endocytic pathway: (a) to sort PDGFr  out of 
a peripheral, postendocytic compartment into later steps 
in the endocytic pathway; and (b) to regulate both the ki- 
netics of membrane flow and the morphology of endo- 
somes containing lysosomally directed and recycling mole- 
cules. 
Figure 6. Effects of wortman- 
nin on endosomes containing 
transferrin. HepG2, COS-7, 
and HeLa cells were incubated 
with Texas red-transferrin (5 
p.g/ml) for 30 min at 37°C. 
Wortmannin (bottom) was 
added to the medium to 
achieve a final concentration 
of 50 nM, and incubations 
were continued for a further 20 
min. Cells were washed twice 
in ice-cold PBS, fixed in 4% 
formaldehyde, and visualized. 
Images comprise an individual 
optical section from the middle 
of the cell after restoration, as 
described in Materials and 
Methods. Arrowheads and ar- 
rows point to enlarged endo- 
somes and tubulated structures 
found in wortmannin-treated 
cells. Bars, 10 ~m. 
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Figure 7. Time course of the 
effect of wortmannin on endo- 
somes containing transferrin. 
HepG2 ceils were incubated 
with TR-transferrin for 50 min 
at 37°C, Wortmannin (50 nM) 
was present for the last 5, 10, 
or 20 min of incubation as indi- 
cated. Ceils were washed twice 
in ice-cold PBS, fixed in 4% 
formaldehyde, and visualized. 
Images are the sum of 20 indi- 
vidual optical sections compris- 
ing the middle of the cell after 
restoration, as described in 
Materials and Methods. 
Effects of Wortmannin on Endogenous 
Phosphoinositide L vels 
An important question raised by these findings is whether 
specific phosphoinositide products of PI-3 kinases are in- 
volved in mediating both receptor sorting and organelle 
morphology in the endocytic pathway. To begin to address 
this question, we measured the levels of endogenous phos- 
phoinositides in cells grown and treated exactly as de- 
scribed in the experiment shown in Fig. 7. Under these 
conditions, cells are exponentially growing, and are de- 
prived of serum for only 2-3 h. The levels of endogenous 
4o0 Uptake 4o0 Recycling 
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Figure 8. Effects of wortmannin on the internalization and recy- 
cling of transferrin. (Left) HepG2 cells were exposed to wort- 
mannin (50 nM) for 10 rain, and then to 125I-transferrin. Wort- 
mannin (WTM) was present hroughout the incubation. At the 
times indicated, cells were washed, and internalized radioactivity 
measured. (Right) Cells were incubated with 125I-transferfin for 
60 min, and then exposed to wortmannin for 10 rain. Ceils were 
then washed three times with ice-cold PBS, and placed in media 
at 37°C containing excess unlabeled transferrin, in the absence or 
presence of wortmannin (WTM). After the times indicated, the 
radioactivity remaining associated with the cells was quantified. 
Plotted are the means _+ SEM of three experiments performed in 
triplicate, 
phosphoinositides in these cells are shown in Table I. The 
most abundant 3'-phosphoinositide was Plns(3)P, which 
comprised ~75 % of the total pool of 3'-phosphoinositides. 
Within 5 min of exposure of cells to 50 nM wortmannin, 
the levels of Plns(3)P decreased by 70%, but remained un- 
changed thereafter. In contrast, the levels of Plns(3,4,5)P3 
decreased by 50% after 5 min of exposure to wortmannin, 
and were undetectable after 10 min of incubation with the 
toxin. Interestingly, the levels of Plns(3,4)P2 did not de- 
crease in response to wortmannin. These r sults suggest 
that under conditions of exponential growth, 30% of cellu- 
lar Plns(3)P, and most of the cellular pool of Plns(3,4)P2 
are generated by wortmannin-insensitive PI-3 kinase/s. 
Similarities and Differences between the Effects of 
Wortmannin and BFA 
The tubutation of endosomes caused by wortmannin was 
reminiscent of the extensively reported effect of BFA (21, 
38), which causes the extension of long, interconnected tu- 
Table L Time Course of the Effects of Wonvru~nin o the Levels 
of Endogenous Phosphoinositides in Rapidly Growing HepG2 
Cells 
Time PIns(3)P PIns(3,4)P2 Plns(3,4,5)P3 Plns(4)P Plns(4,5)P2 
min 
0 13,053 2,706 1,172 527,060 1,027,909 
5 4,517 5,560 570 452,303 977,197 
10 4,533 3,102 0 537,946 1,021,332 
20 4,732 5,101 0 478,838 1,063,518 
Exponentially growing cells were labeled with [32p]orthophosphate for 2 h as de- 
scribed in Materials and Methods, and treated with wortmannin (50 nM) for the times 
indicated. Monolayers were then scraped off the culture dishes, and lipids extracted, 
deacylated and separated by HPLC as described (1). The radioactivity in each deacyla- 
tion product was expressed as total cpndpeak. The experiment was repeated twice with 
indentical qualitative results. Shown are the averaged raw values from these two inde- 
pendent experiments, which varied by ~20%. 
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bules from endocytic and secretory organelles. The mech- 
anism whereby BFA elicits these morphological changes 
has been partially elucidated, and appears to involve an in- 
hibition of cytosolic-coat assembly. We reasoned that a 
comparison of the effects of wortmannin and BFA on en- 
docytic organelle structure and function might suggest 
mechanisms whereby wortmannin, and thus PI-3 kinase, 
function in the endocytic pathway. Therefore, we com- 
pared the effects of these toxins on cytosolic-coat protein 
assembly (Fig. 9), PDGFr trafficking (see Figs. 10 and 11), 
and endosome morphology (see Figs. 12 and 13). 
To determine whether wortmannin, like BFA, would af- 
fect the assembly of known cytosolic oats, the distribution 
of [3COP, clathrin, and ~/-adaptin were compared (Fig. 9). 
BFA blocked the assembly of coatomer, as evidenced by 
the change in the distribution of 13COP from a tightly con- 
centrated juxtanuclear structure to a disperse distribution 
(Fig. 9, middle). BFA also blocked the assembly of ~/-adap- 
tin at the TGN (29), as evidenced by the loss of ~/-adaptin 
and clathrin staining in a distinctly concentrated area next 
to the nucleus (Fig. 9, bottom and top). In contrast, wort- 
mannin had no detectable ffects on the distribution of 
clathrin, 13COP, or "v-adaptin (Fig. 9, compare columns C 
and WTM). Similar results were observed at concentra- 
tions of wortmannin up to 500 nM (not shown). These re- 
sults indicate that unlike BFA, wortmannin does not in- 
hibit the assembly of cytosolic coats in the secretory 
pathway. In addition, wortmannin had no effect on the 
ability of BFA to cause disassembly of coat components 
(not shown). Thus, the ffects of wortmannin appear to be 
restricted to the endocytic pathway. One possible reason 
for this selectivity could be the presence, in the secretory 
pathway, of specific PI-3 kinase isoforms that are less sen- 
sitive to inhibition by wortmannin (reference 32; and Table I). 
The effects of BFA and wortmannin on the subcellular 
localization and degradation of PDGFr were compared 
(Fig. 10). Cells were left untreated (Fig. 10, top left and 
right) or treated for 10 min with wortmannin (bottom left) 
or BFA (bottom right) and then exposed to PDGF (top 
right and bottom) for 60 min (Fig. 10). Both in the pres- 
ence or absence of BFA receptors moved from the cell 
surface to large juxtanuclear vesicles (Fig. 10, right). Some 
tubulated structures containing PDGFr could be detected 
in BFA:treated cells (Fig. 10, bottom right), suggesting 
that, like other markers of the lysosomal pathway (39) 
PDGFr can exit the tubulated endosomal system induced 
by BFA. In contrast, in cells treated with wortmannin the 
movement of receptors from peripheral structures into 
pericentriolar vesicles was blocked (Fig. 10, bottom left). 
Addition of both toxins together blocked PDGFr move- 
ment to pericentriolar vesicles, indicating that BFA does 
not reverse the inhibitory effects of wortmannin on recep- 
tor trafficking (not shown). Furthermore, BFA had no sig- 
nificant effect on PDGF-indueed receptor degradation 
(Fig. 11, BFA), whereas wortmannin fully inhibited this 
process (Fig. 11, WTM). Taken together, the results shown 
in Figs. 11 and 12 indicate that the alterations of organelle 
structure induced by BFA do not per se block PDGFr traf- 
ficking. Furthermore, these results suggest that the effects 
of wortmannin on organelle structure and PDGFr traffick- 
ing are independent. 
The results shown above indicate two important differ- 
ences between the effects of wortmannin and BFA; the ef- 
fects of the former appear to be restricted to the endocytic 
pathway, and they also include an inhibition of PDGFr 
sorting probably resulting from inhibition of PI-3 kinase 
activity bound to the PDGFr cytoplasmic domain. Never- 
theless, both wortmannin and BFA cause tubulation of or- 
Figure 9. Effects of wort- 
mannin and BFA on cytoso- 
lic coat distribution. HepG2 
cells were treated with 10 
txM BFA (BFA), 50 nM 
wortmannin (WTM), or 
nothing (C) for 10 rain. Cells 
were fixed, permeabilized, 
and incubated with rabbit 
polyclonal antibodies against 
either the clathrin heavy 
chain (Chc) (top) or [3COP 
(middle) or with a mouse 
monoclonal ntibody against 
-¢-adaptin (bottom). Primary 
antibodies were detected 
with FIT@labeled secondary 
antibodies against rabbit or 
mouse immunoglobulins 
(Tago). Shown in each panel 
is one section through the 
middle of the cell after esto- 
ration. Bars, 15 ixm. 
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Figure I0. Effects of BFA and wortmannin on PDGF receptor 
distribution. HepG2 cells were treated with nothing (top left), 50 
nM wortmannin (bottom left), 50p.M brefeldin-A (bottom right) 
for 10 min, and then exposed to PDGF (20 ng/ml) for 60 min at 
25°C (top right and bottom). Cells were fixed, permeabilized, and 
stained with a monoclonal antibody against he PDGF receptor 
and anti-mouse immunoglobulins coupled to FITC. Arrowheads 
indicate juxtanuclear vesicles, and arrows indicate tubular struc- 
tures containing PDGFr. Bars, 10 I~m. 
Figure 11. Effects of wort- 
mannin and BFA on PDGF 
receptor degradation. HepG2 
cells expressing the wild-type 
PDGF receptor were labeled 
with [35S]methionine, and in- 
cubated for 2 h in the ab- 
sence ( - )  or presence (+) of 
PDGF (50 ng/ml). BFA 
(BFA) (50 p.M) or wortman- 
nin (50 nM) were added 10 
min before exposure to 
PDGF. Receptor immuno- 
precipitates were resolved on 
SDS-PAGE, and exposed to 
autoradiographic film. The 
expected position of the 
PDGF receptor is indicated 
with an arrow. Bars repre- 
sent the means _+ SEM of 
densitometric scans ob- 
tained from five independent 
experiments. 
later steps in the lysosomal degradative pathway. This ar- 
rest in trafficking is also observed when PDGFr  mutants 
impaired in PI-3 kinase binding are analyzed. Thus, it ap- 
pears likely that he association of PI-3 kinase activity with 
the PDGFr  cytoplasmic domain is necessary for its transit 
from a peripheral, early endocytic compartment into the 
lysosomal degradative pathway. Second, wortmannin causes 
a dramatic alteration in the morphology of endosomal ele- 
ments containing transferrin and fluid phase markers. This 
latter effect is similar to that induced by the fungal toxin 
ganelles in the endocytic pathway. The effects of BFA 
have been shown to be blocked by ALF4-,  which inhibits 
the hydrolysis of GTP bound to ARF  proteins, and results 
in a persistent activation of ARF  and a concomitant stabi- 
lization of cytosolic oats on membranes (9, 21). To deter- 
mine whether similar mechanisms might be involved in the 
effects of wortmannin and BFA on organelle morphology, 
we compared their sensitivity to ALF4-.  
Within 10 min of exposure of HepG2 cells to wortman- 
nin or BFA,  tubules containing transferrin could be ob- 
served (Fig. 12, arrowheads). The tubulated pattern in- 
duced by wortmannin was different from that of BFA in 
that condensation of endosomes was more pronounced, 
and tubules appeared to be shorter than those induced by 
BFA.  However, the effects of both wortmannin and BFA 
were similarly blocked by pre-treatment of cells with 
ALF4-  (30 mM NaF + 50 IxM AICI3). Similarly, the effect 
of wortmannin on endosomes containing LY was com- 
pletely blocked by pre-treatment with ALF4-  (Fig. 13). 
Discussion 
In this paper we have shown that wortmannin causes two 
distinguishable effects on trafficking in the endocytic path- 
way in mammal ian cells. First, it appears to block the tran- 
sit of activated PDGFr  from a peripheral compartment to 
Figure 12. The effects of wortmannin and BFA on endosomes 
containing transferrin are blocked by ALF4-. HepG2 ceils were 
incubated with TR-transferrin for 30 min. ALF4- (30 mM NaF + 
50 p.M AICI3) was then added (+ALF4- ), and incubations contin- 
ued for 5 min. Wortmannin (bottom) or BFA (top) were then 
added at a final concentration of 50 nM or 50 pLM, respectively. 
After an additional 20 rain, cells were washed three times in ice- 
cold PBS, fixed in formaldehyde and visualized. Arrowheads in- 
dicate tubular structures, and arrows point to enlarged endo- 
somes observed in response to wortmannin or BFA. Bars, 10 p.M. 
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Figure 13. The effects of wort- 
mannin on LY-containing en- 
dosomes are blocked by 
ALF4-. Cells were incubated 
for 20 min with LY, and then 
for 5 min in the absence (left 
and middle) or presence (right) 
of ALF4- (30 mM NaF + 50 
IxM AIC13). Wortmannin 
(WTM) (50 nM) was then 
added (middle and right), and 
after 15 min cells were fixed 
and stained as described 
above. Arrows point to vesicu- 
lar structures containing LY, 
and arrowheads are aligned on 
tubulated structures which ap- 
pear in response towortmannin. 
BFA, and can also be blocked by pre-treatment of cells 
with ALF4-. These results suggest the hypothesis that 
ALF4- sensitive GTP-binding proteins may operate down- 
stream of PI-3 kinase. 
Points in the Endocytic Pathway Where PI-3 Kinase Is 
Required for PDGFr Trafficking 
The high degree of co-localization of PDGFr and LY, and 
low degree of co-localization with transferrin shown in this 
study (Figs. 1 and 2) suggest hat both PDGFr and fluid- 
phase molecules enter the sorting endosome, and are 
sorted together from recycling molecules. The mecha- 
nisms whereby activated wild-type PDGFr segregate from 
recycling molecules and maintain a co-localization with 
fluid phase markers is not known, but might involve its re- 
tention in the vesicular portion of the sorting endosome 
(10, 11, 22). Interestingly, however, in contrast o wild- 
type PDGFr, F40/51 mutant PDGFr remained ispersed 
in small structures at the cell periphery, and displayed lit- 
tle co-localization either with LY or with transferrin, 
which localized in more pericentriolar regions. Similarly, 
in cells treated with wortmannin wild-type PDGFr main- 
tained a peripheral distribution, and lost the pronounced 
co-localization with LY observed in nontreated cells (Fig. 
4). These results suggest that in the absence of PI-3 kinase 
activity, PDGFr trafficking is arrested at a very early step 
after internalization, before reaching the sorting endo- 
some. The nature of the peripheral structures where 
PDGFr are arrested in the absence of PI-3 kinase is not 
known, but these structures did not display tubulation and 
enlargement in response to wortmannin (not shown), sug- 
gesting they are physically separate and functionally dif- 
ferent from endosomes containing transferrin or Lucifer 
yellow, which tubulate in response to wortmannin. The re- 
sults also support he hypothesis that the effect of wort- 
mannin to block PDGFr sorting is independent of its ef- 
fect on the structure of endosomes containing transferrin 
or LY. 
Potential Mechanisms Involved in the Effects of 
Wortmannin on Organelle Morphology 
As with any other study involving the use of inhibitors, the 
possibility exists that this toxin may have direct targets 
other than PI-3 kinase. In our studies, we observed a close 
temporal correlation between the effects of wortmannin to 
decrease the endogenous levels of Plns(3)P (Table I) and 
to cause changes in organelle morphology (Fig. 7), as well 
as an identical dose-dependency for these effects (not il- 
lustrated). Wortmannin had no effect on the levels of 
Plns(4)P or Plns(4,5)P2, and at the concentrations u ed in 
these studies, wortmannin is not known to directly inhibit 
other protein or lipid kinases. Thus, the results presented 
here suggest, although they do not prove, that the effects 
of wortmannin on organelle morphology are indeed due to 
its inhibitory effect on PI-3 kinase activity. 
Mammalian PI-3 kinases catalyze the formation of 
Plns(3)P, Plns(3,4)P2, and Plns(3,4,5)P3, but the specific 
physiological functions of each of these lipids are un- 
known. In our studies, low concentrations of wortmannin 
caused a rapid and pronounced ecrease in endogenous 
Plns(3)P under conditions of exponential growth. A simi- 
lar decrease in Plns(3)P occurs under conditions of serum 
starvation (Duckworth, B., and L. Cantley, unpublished 
results). Importantly, the effects of wortmannin on or- 
ganelle structure are evident bo h in exponentially grow- 
ing (Figs. 6 and 7) and in serum-deprived cells (Fig. 4 and 
data not shown). Because Plns(3)P is the only lipid detect- 
able under both of these conditions (Table I; and refer- 
ence 1), and it decreases in response to wortmannin with a 
time course that closely parallels the appearance of alter- 
ations in endosome morphology (compare Table I and Fig. 
7), it is likely that PI-3 P is the lipid product of PI-3 kinase 
involved in the control of organelle structure. 
PDGF internalization i to the lysosomal pathway, which 
is analyzed in serum-starved cells, is closely paralleled by 
the appearance of Plns(3,4)P2 and Plns(3,4,5)P3, without 
a detectable increase in Plns(3)P (1). The appearance of 
both of Plns(3,4)P2 and Plns(3,4,5)P3 in response to 
PDGF is thought o result from the recruitment and stimu- 
lation of the pl10/p85 PI-3 kinase isoform to the PDGF re- 
ceptor cytoplasmic domain. This PI-3 kinase isoform is 
acutely sensitive to wortmannin, and in fact the PDGF- 
induced production of Plns(3,4)P2 and Plns(3,4,5)P3 is 
completely inhibited by wortmannin (Duckworth, B., and 
L. Cantley, personal communication). Thus, either or both 
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PIns(3,4)P2 and Plns(3,4,5)P3 could be involved in 
PDGFr sorting to the lysosomal pathway. 
The similarity between the effects of wortmannin and 
BFA, consisting mainly in the formation of interconnected 
tubular networks (Figs. 6 and 7 and references 21 and 38), 
suggests that both toxins mayaffect similar targets. The 
targets of BFA appear to include activities that affect he 
exchange of GDP for GTP on ARF1, and thus the activa- 
tion state of this protein (8, 12). Downstream cellular e- 
sponses that are influenced by ARF1 are the binding of cy- 
tosolic--coat proteins like coatomer (20, 26) and ~/-adaptin 
(29), as well as the activity of phospholipase-D (2, 6). It is 
thought that the changes in organeUe morphology elicited 
by BFA result from the impaired binding of cytosolic-coat 
proteins. Although no specific cytosolic-coat proteins 
have been identified in endocytic vesicles, the phenotypic 
responses of these vesicles uggest that such endocytic y- 
tosolic coats exist. Furthermore, isoforms of ARF or 
ARF-related GTP-binding proteins in the endoeytic path- 
way may fulfill a function similar to that of ARF1 (7, 27, 
30, 35). 
The effects of wortmannin on endosomes suggest that 
this toxin may affect he assembly of cytosolic-coat com- 
ponents in the endocytic pathway. Furthermore, the find- 
ings that AIF 4- blocks these effects (Figs. 12 and 13) is 
consistent with the hypothesis that ALFa--sensitive GTP 
binding proteins operate in the endocytic pathway, and 
that these may be regulated by Plns(3)P (Fig. 14). A role 
for phospholipids in the regulation of the activity of GTP- 
ases is consistent with recent reports which indicate a 
marked dependency on phosphoinositides for ARF1 ex- 
change and GAP activities (34, 28). 
An important difference between the effects of BFA 
and wortmannin is the specificity of wortmannin for or- 
ganelles in the endocytic pathway. BFA causes tubulation 
ICOAT PROTEINS I 
T 
ARF ......... ~ ARF 
GDP i GTP 
Nucleotide I 
BFA ~ Exchange 
Pins 
Figure 14. Potential targets for PI-3 kinase. Cytosolic coat-pro- 
tein assembly on membranes i triggered by the activation of 
ARF GTPases by factors that catalyze nucleotide xchange. In 
our model, these factors are activated by PI-3 kinase products, 
for example Plns(3)P. The inhibition of PI-3 kinase activity by 
wortmannin results in a decrease in 3'-phosphoinositides, and 
thus to inhibition of nucleotide xchange. The process of nucleo- 
tide exchange is directly inhibited by BFA. The specificity of 
wortmannin for the endocytic pathway may result from the pres- 
ence of PI-3 kinase activities that are less sensitive to the toxin 
which may be localized to the Golgi apparatus and other or- 
ganeUes in the secretory pathway. 
of organelles both in the secretory and endocytic path- 
ways, and the former effect is accompanied by inactivation 
of ARF1 and disassembly of Golgi-specific oats. The 
specificity of wortmannin for the endocytic pathway does 
not rule out the possibility that PI-3 kinase may operate 
both in the secretory and endocytic pathways to regulate 
coat assembly, as proposed in Fig. 14, because wortmannin 
does not completely deplete the endogenous levels of 3'- 
phosphoinositides. Table I indicates that a significant level 
of PIns(3)P remains in cells after treatment with wortman- 
nin. This may represent the product of PI-3 kinases that 
are less sensitive to wortmannin, which have been previ- 
ously described (32, 33), and which may be localized to the 
Golgi apparatus and/or other organelles in the secretory 
pathway. 
In summary, the results shown here suggest that mam- 
malian PI-3 kinases function at at least wo steps in the en- 
docytic pathway. First, PI-3 kinase activity appears to be 
required for the exit of internalized PDGFr from an early 
endocytic intermediate to sorting endosomes and later 
steps in the lysosomal degradative pathway. This process 
may require the localized synthesis of higher phosphory- 
lated lipids Plns(3,4)P2 and Pins (3,4,5)P3, which appear 
upon association of the p85/p110 PI-3 kinase with the cyto- 
plasmic domain of the PDGF receptor (1). A second, inde- 
pendent role of PI-3 kinase may be in maintaining the ve- 
sicular morphology of endosomes. It is likely that this 
function requires Plns(3)P, which is the most abundant 3' 
phosphoinositide incells, and is present both in exponen- 
tially growing and serum-deprived cells. Because it is 
likely that the maintenance of vesicular organelle mor- 
phology requires cytosolic-coat proteins and the activity 
of specific small GTP-binding proteins, our results uggest 
that downstream targets of PI-3 kinase products may in- 
clude such cellular components. 
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